Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,2 CAD | -4,76% | -20,00% | +37,93% |
Vakgebied
Aantal werknemers: 7
Verkoop per activiteit
CAD in miljoen | 2024 | Gewicht | Delta |
---|---|---|---|
Pharmaceutical
100,0
%
| 2 | 100,0 % | - |
Verkoop per regio
CAD in miljoen | 2024 | Gewicht | Delta |
---|---|---|---|
Canada
100,0
%
| 2 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Luc Grégoire
CEO | Chief Executive Officer | 64 | 17-03-23 |
Colette Laurin
DFI | Director of Finance/CFO | - | 28-12-15 |
Pascal Brabant
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
André Boulet
CTO | Chief Tech/Sci/R&D Officer | - | 27-03-15 |
Nathalie Boucher
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
André Boulet
CTO | Chief Tech/Sci/R&D Officer | - | 27-03-15 |
Luc Grégoire
CEO | Chief Executive Officer | 64 | 17-03-23 |
Kathryn Gregory
BRD | Director/Board Member | 62 | 28/02 |
Jean Forcione
BRD | Director/Board Member | 58 | 12-05-23 |
David Baker
CHM | Chairman | 60 | 12-05-23 |
Louis Flamand
BRD | Director/Board Member | - | 25-05-17 |
Edouard Dahl
BRD | Director/Board Member | - | 12-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 148 222 531 | 127 172 676 ( 85,80 %) | 0 | 85,80 % |
Bedrijfsgegevens
Devonian Health Group, Inc.
360, rue des Entrepreneurs
G5V 4T1, Montmagny
+
http://www.groupedevonian.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,93% | 21,7 mln. | |
+29,18% | 684 mld. | |
+30,34% | 568 mld. | |
-3,83% | 361 mld. | |
+17,56% | 329 mld. | |
+4,27% | 284 mld. | |
+16,21% | 240 mld. | |
+9,66% | 208 mld. | |
-6,83% | 200 mld. | |
+7,37% | 166 mld. |